科斯莫斯健康在提交2023年年度报告和2024年第一季度财务报告后恢复了纳斯达克的合规性. 
Cosmos Health regained Nasdaq compliance after filing 2023 Annual Report and Q1 2024 financials.
Cosmos Health Inc.是一家多样化的保健公司,在提交了2023年表格10-K和10-Q1-2024财务年度报告后,重新完全遵守了Nasdaq的列名要求。 Cosmos Health Inc., a diversified healthcare company, regained full compliance with Nasdaq listing requirements after filing its 2023 Annual Report on Form 10-K and Q1 2024 financials on Form 10-Q. 该公司在2024年4月和5月面临不履约通知,但满足了Nasdaq的申报规则,并在7月也符合最低竞标价规则。 The company faced non-compliance notifications in April and May 2024 but satisfied Nasdaq's Filing Rule, and also met the Minimum Bid Price Rule in July. 科斯莫斯健康成立于2009年,在药品,营养药品,远程医疗和研发领域运营. Cosmos Health was founded in 2009 and operates in pharmaceuticals, nutraceuticals, telehealth, and R&D.
